T1	Participants 97 154	invasive aspergillosis in high-risk haematology patients:
T2	Participants 257 317	haematology patients at high risk of invasive aspergillosis.
T3	Participants 616 774	eligible patients were adults undergoing allogeneic stem-cell transplantation or chemotherapy for acute leukaemia, with no history of invasive fungal disease.
T4	Participants 1801 1906	240 eligible patients were recruited from six Australian centres between Sept 30, 2005, and Nov 19, 2009.
T5	Participants 2656 2689	in high-risk haematology patients
